Skip to content
10-K/A

Annual Report

HUAIZHONG HEALTH GROUP INC.

0001640334-23-000947

← back to feed
Filed
May 24, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 27, 2023 31.52M sh
Operating Cash Flow FY 2022 · Oct 31, 2022 −$30.57K
Operating Cash Flow restated FY 2022 · Oct 31, 2021 −$31.79K
Stockholders Equity FY 2022 · Oct 31, 2022 −$79.47K
Stockholders Equity FY 2022 · Oct 31, 2021 −$50.3K
Stockholders Equity FY 2022 · Oct 31, 2020 −$19.47K
Current Liabilities FY 2022 · Oct 31, 2022 $80.72K
Current Liabilities FY 2022 · Oct 31, 2021 $50.3K
Total Liabilities FY 2022 · Oct 31, 2022 $80.72K
Total Liabilities FY 2022 · Oct 31, 2021 $50.3K
Current Assets FY 2022 · Oct 31, 2022 $1.25K
Current Assets FY 2022 · Oct 31, 2021 $0
Total Assets FY 2022 · Oct 31, 2022 $1.25K
Total Assets FY 2022 · Oct 31, 2021 $0
Sga Expense FY 2022 · Oct 31, 2022 $3K
Sga Expense FY 2022 · Oct 31, 2021 $2.91K
Net Income FY 2022 · Oct 31, 2022 −$29.17K
Net Income FY 2022 · Oct 31, 2021 −$30.83K
Operating Income FY 2022 · Oct 31, 2022 −$29.17K
Operating Income FY 2022 · Oct 31, 2021 −$30.83K
Revenue FY 2022 · Oct 31, 2022 $0
Revenue FY 2022 · Oct 31, 2021 $0